Latest Period
Q4 2025
Security Snapshot
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) Institutional Ownership
CUSIP: 18914F103
13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026
Institutions Reporting
189
Shares (Excl. Options)
126,237,708
Price
$2.35
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock
- Symbol
- CLOV on Nasdaq
- Shares outstanding
- 416,598,522
- Price per share
- $1.76
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 126,237,708
- Total reported value
- $296,707,700
- % of total 13F portfolios
- 0%
- Share change
- -9,433,753
- Value change
- -$28,410,372
- Number of holders
- 189
- Price from insider filings
- $1.76
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock is tracked under CUSIP 18914F103.
- 189 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 189 to 34 between Q4 2025 and Q1 2026.
- Reported value moved from $296,707,700 to $2,562,857.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 189 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 18914F103?
CUSIP 18914F103 identifies CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 18914F103:
Significant Owners of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 7.2% | $83,180,072 | 29,813,646 | BlackRock, Inc. | 30 Jun 2025 |
As of 31 Dec 2025, 189 institutional investors reported holding 126,237,708 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV). This represents 30% of the company’s total 416,598,522 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) together control 27% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7.7% | 32,280,859 | +6.2% | 0% | $75,860,020 |
| VANGUARD GROUP INC | 5.6% | 23,485,912 | +1.8% | 0% | $55,191,894 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 9,791,208 | +0.73% | 0% | $23,013,307 |
| STATE STREET CORP | 2.2% | 9,320,183 | +4.1% | 0% | $21,902,430 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.1% | 4,690,904 | +9.8% | 0% | $11,023,623 |
| RENAISSANCE TECHNOLOGIES LLC | 1.1% | 4,491,141 | -42% | 0.02% | $10,554,181 |
| PNC Financial Services Group, Inc. | 0.9% | 3,763,851 | -16% | 0% | $8,845,050 |
| DIMENSIONAL FUND ADVISORS LP | 0.87% | 3,634,325 | +70% | 0% | $8,541,992 |
| NORTHERN TRUST CORP | 0.76% | 3,178,430 | -5.8% | 0% | $7,469,311 |
| MORGAN STANLEY | 0.62% | 2,599,028 | +29% | 0% | $6,107,716 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.56% | 2,325,253 | -14% | 0.01% | $5,464,345 |
| GOLDMAN SACHS GROUP INC | 0.43% | 1,781,239 | +106% | 0% | $4,185,911 |
| UBS Group AG | 0.32% | 1,315,324 | -42% | 0% | $3,091,011 |
| Bank of New York Mellon Corp | 0.28% | 1,172,758 | -1.7% | 0% | $2,755,981 |
| CITADEL ADVISORS LLC | 0.28% | 1,147,940 | -23% | 0% | $2,697,659 |
| GROUP ONE TRADING LLC | 0.26% | 1,087,975 | -12% | 0.08% | $2,556,741 |
| Nuveen, LLC | 0.21% | 883,536 | 0% | 0% | $2,076,310 |
| Invesco Ltd. | 0.21% | 863,197 | -9.9% | 0% | $2,028,513 |
| Swiss National Bank | 0.2% | 828,400 | +2.6% | 0% | $1,946,740 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.19% | 779,801 | +17% | 0% | $1,832,533 |
| Soviero Asset Management, LP | 0.18% | 750,000 | -46% | 0.92% | $1,762,500 |
| PRINCIPAL FINANCIAL GROUP INC | 0.17% | 709,482 | +46% | 0% | $1,667,282 |
| OP Asset Management Ltd | 0.16% | 655,112 | +65% | 0.02% | $1,539,513 |
| IMC-Chicago, LLC | 0.15% | 642,964 | -25% | 0.03% | $1,510,965 |
| BARCLAYS PLC | 0.15% | 637,279 | +10% | 0% | $1,497,605 |
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 1,466,378 | $2,562,857 | -$1,251,503 | $1.76 | 34 |
| 2025 Q4 | 126,237,708 | $296,707,700 | -$28,410,372 | $2.35 | 189 |
| 2025 Q3 | 135,271,235 | $413,882,154 | -$32,444,876 | $3.06 | 199 |
| 2025 Q2 | 146,128,655 | $407,670,376 | +$107,801,104 | $2.79 | 197 |
| 2025 Q1 | 105,851,444 | $380,012,727 | +$48,891,922 | $3.59 | 197 |
| 2024 Q4 | 92,775,680 | $292,290,234 | +$33,084,501 | $3.15 | 173 |
| 2024 Q3 | 82,031,282 | $231,318,941 | +$27,492,527 | $2.82 | 154 |
| 2024 Q2 | 73,223,084 | $90,062,636 | -$13,953,079 | $1.23 | 121 |
| 2024 Q1 | 89,442,327 | $71,016,376 | -$5,911,907 | $0.79 | 132 |
| 2023 Q4 | 96,511,448 | $91,887,186 | +$2,277,396 | $0.95 | 141 |
| 2023 Q3 | 93,620,098 | $101,107,320 | -$3,078,475 | $1.08 | 138 |
| 2023 Q2 | 96,771,026 | $86,789,528 | -$22,993,945 | $0.90 | 140 |
| 2023 Q1 | 122,809,816 | $103,788,732 | -$1,403,557 | $0.85 | 150 |
| 2022 Q4 | 126,098,230 | $117,195,358 | +$72,200 | $0.93 | 167 |
| 2022 Q3 | 123,383,724 | $209,751,673 | -$931,167 | $1.70 | 150 |
| 2022 Q2 | 122,450,162 | $262,010,857 | +$44,394,028 | $2.14 | 156 |
| 2022 Q1 | 99,563,575 | $353,476,882 | -$114,782,509 | $3.55 | 147 |
| 2021 Q4 | 130,139,458 | $484,243,395 | +$81,897,100 | $3.72 | 144 |
| 2021 Q3 | 105,648,029 | $780,734,717 | -$325,418,528 | $7.39 | 131 |
| 2021 Q2 | 141,911,833 | $1,889,729,052 | -$201,269,843 | $13.32 | 132 |
| 2021 Q1 | 160,035,962 | $1,206,298,896 | +$1,205,006,987 | $7.56 | 118 |
| 2020 Q4 | 74,874 | $1,256,000 | +$837,000 | $16.76 | 9 |
| 2020 Q3 | 0 | $0 | -$113,000 | $3.75 | 0 |
| 2020 Q2 | $3.75 | 0 | |||
| 2020 Q1 | 15,000 | $113,000 | $7.53 | 1 | |
| 2019 Q4 | $3.75 | 0 | |||
| 2019 Q3 | $3.75 | 0 | |||
| 2019 Q2 | $3.75 | 0 | |||
| 2019 Q1 | $3.75 | 0 |